3月26日，联邦制药(03933)盘中下跌3.81%，截至13:50，报14.12元/股，成交3.0亿元。
联邦制药国际控股有限公司主要从事药品的研发、生产和销售，拥有制剂、原料、生物、动保四大业务板块，九家生产研发实体的综合性制药集团，全球销售网络覆盖，员工人数达到15000余人。在荣膺多项行业荣誉基础上，公司在2022年的中国化药企业和医药工业百强排行榜分别位居第16和27名。
截至2024年年报，联邦制药营业总收入137.59亿元、净利润26.6亿元。
3月24日，2024年度末期每股派人民币0.28元(相当于港币0.303204元(计算值))，特别股息每股派人民币0.12元(相当于港币0.129945元(计算值))，除权除息日2025-07-08(董事会预案)。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.